Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -154.89% is 65% above its 5-year average of -439.28%, near the high end of its 5-year range (-2154.05%–0.00%).
280.75% below its 12-month average of -40.68%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -39.62%.
RETURN ON ASSETS (ROA)
-154.89%
RETURN ON ASSETS (ROA) AVG TTM
-40.68%
RETURN ON ASSETS (ROA) AVG 3Y
-87.98%
RETURN ON ASSETS (ROA) AVG 5Y
-439.28%
RETURN ON ASSETS (ROA) AVG 10Y
-337.63%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-280.75%
CURRENT VS 3Y AVG
-76.04%
CURRENT VS 5Y AVG
+64.74%
CURRENT VS 10Y AVG
+54.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.35%
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
-466.33%
vs the sector median at left
BioVie Inc.
Market Cap
$10.86M
Return on Assets (ROA)
-154.89%
TTM Avg
-40.68%
3Y Avg
-87.98%
5Y Avg
-439.28%
Market Cap
$10.73M
Return on Assets (ROA)
-88.09%
TTM Avg
-90.94%
3Y Avg
-60.82%
5Y Avg
-50.49%
Market Cap
$10.74M
Return on Assets (ROA)
-77.94%
TTM Avg
-178.68%
3Y Avg
-1009.31%
5Y Avg
-2782.57%
Market Cap
$10.74M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$11.21M
Return on Assets (ROA)
-46.21%
TTM Avg
-17.41%
3Y Avg
-49.70%
5Y Avg
-52.01%
Market Cap
$11.27M
Return on Assets (ROA)
-26.45%
TTM Avg
-58.62%
3Y Avg
-47.64%
5Y Avg
-51.16%
Market Cap
$10.27M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$11.50M
Return on Assets (ROA)
-198.70%
TTM Avg
-189.50%
3Y Avg
-187.22%
5Y Avg
-200.18%
Market Cap
$9.88M
Return on Assets (ROA)
-157.56%
TTM Avg
-309.44%
3Y Avg
-441.71%
5Y Avg
-440.28%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioVie Inc. (BIVI) | $10.86M | -154.89% | -40.68% | -87.98% | -439.28% |
| Lifeward Ltd. (LFWD)vs › | $10.73M | -88.09% | -90.94% | -60.82% | -50.49% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.74M | -77.94% | -178.68% | -1009.31% | -2782.57% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -185.94% | -166.39% | -133.67% | -110.62% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | -46.21% | -17.41% | -49.70% | -52.01% |
| Biofrontera Inc. (BFRI)vs › | $11.27M | -26.45% | -58.62% | -47.64% | -51.16% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -404.58% | -269.82% | -269.82% | -269.82% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | -198.70% | -189.50% | -187.22% | -200.18% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.88M | -157.56% | -309.44% | -441.71% | -440.28% |
| Ainos, Inc. (AIMD)vs › | $9.94M | -73.89% | -61.17% | -50.83% | -128.36% |
ROA
-154.9%
ROE
-214.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | 0.00% |
| 2025-06-30 | -81.36% |
| 2024-06-30 | -127.42% |
| 2023-06-30 | -143.16% |
| 2022-06-30 | -129.68% |
| 2021-06-30 | -2154.05% |
| 2020-06-30 | -800.26% |
| 2019-06-30 | -94.94% |
| 2018-06-30 | -110.92% |
| 2017-06-30 | -56.30% |
| 2016-06-30 | -15.88% |
| 2015-06-30 | -86.47% |
| 2014-06-30 | -96.70% |
| 2013-06-30 | -13.85% |
